BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24434384)

  • 41. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.
    Shi K; Wang F; Jiang H; Liu H; Wei M; Wang Z; Xie L
    Dig Dis Sci; 2014 Sep; 59(9):2109-17. PubMed ID: 24828917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
    Nolin TD; Ouseph R; Himmelfarb J; McMenamin ME; Ward RA
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1588-94. PubMed ID: 20538838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Arctium lappa L. (Burdock) root tea on inflammatory status and oxidative stress in patients with knee osteoarthritis.
    Maghsoumi-Norouzabad L; Alipoor B; Abed R; Eftekhar Sadat B; Mesgari-Abbasi M; Asghari Jafarabadi M
    Int J Rheum Dis; 2016 Mar; 19(3):255-61. PubMed ID: 25350500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients.
    Çolak H; Kilicarslan B; Tekce H; Tanrisev M; Tugmen C; Aktas G; Kursat S
    Ther Apher Dial; 2015 Feb; 19(1):56-62. PubMed ID: 25628169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Albarrán-Planelles C; Rodríguez C; Linares-Barrios M
    Mediators Inflamm; 2017; 2017():2450401. PubMed ID: 28769536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of chronic inflammation on bone turnover in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Antoniadi G; Kazila P; Dimitriadou M; Sotiriadou E; Koltsida M; Golfinopoulos S; Liakopoulos V; Christopoulou-Apostolaki M
    Ren Fail; 2008; 30(4):431-7. PubMed ID: 18569918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction.
    Friedrich B; Alexander D; Janessa A; Häring HU; Lang F; Risler T
    Kidney Int; 2006 Dec; 70(12):2124-30. PubMed ID: 17063178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C reactive protein in patients with chronic renal diseases.
    Panichi V; Migliori M; De Pietro S; Taccola D; Bianchi AM; Norpoth M; Metelli MR; Giovannini L; Tetta C; Palla R
    Ren Fail; 2001; 23(3-4):551-62. PubMed ID: 11499569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants.
    Caliskan Y; Yelken B; Gorgulu N; Ozkok A; Yazici H; Telci A; Turkmen A; Yildiz A; Sever MS
    J Ren Nutr; 2012 Mar; 22(2):258-267. PubMed ID: 22056149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.
    Samouilidou EC; Grapsa EJ; Kakavas I; Lagouranis A; Agrogiannis B
    Int Urol Nephrol; 2003; 35(3):393-7. PubMed ID: 15160547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor.
    Hasebe K; Gray L; Bortolasci C; Panizzutti B; Mohebbi M; Kidnapillai S; Spolding B; Walder K; Berk M; Malhi G; Dodd S; Dean OM
    Acta Neuropsychiatr; 2017 Dec; 29(6):337-346. PubMed ID: 28318471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study.
    Trimarchi H; Mongitore MR; Baglioni P; Forrester M; Freixas EA; Schropp M; Pereyra H; Alonso M
    Clin Nephrol; 2003 Jun; 59(6):441-6. PubMed ID: 12834176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
    Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
    J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of administration of oral N-acetylcysteine to reduce oxidative stress in chronic hemodialysis patients: A double-blind, randomized, controlled clinical trial.
    Shahbazian H; Shayanpour S; Ghorbani A
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):88-93. PubMed ID: 26787572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.
    Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Noorbala AA; Hashemi-Nazari SS; Mansournia MA
    Eur J Clin Pharmacol; 2014 Jun; 70(6):655-65. PubMed ID: 24643636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum C-reactive protein (CRP) in association with various nutritional parameters in maintenance hemodialysis patients.
    Nasri H
    Bratisl Lek Listy; 2005; 106(12):390-5. PubMed ID: 16642663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.
    Tsirpanlis G; Boufidou F; Manganas S; Chantzis K; Bleta A; Stamatelou K; Psimenou E; Nicolaou C
    Blood Purif; 2004; 22(6):518-24. PubMed ID: 15557765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.